Showing results (151-160 of 1,803) with videos related to
Sort By:
Pageof 181
Transplantation and Cellular Therapy|April 25, 2021
Prolonged Lenalidomide Therapy Does Not Impact Autologous Peripheral Blood Stem Cell Mobilization and Collection in Multiple Myeloma Patients: A Single-Center Retrospective AnalysisAndrew J Cowan, Philip A Stevenson, Damian J Green, et al.Transplantation and Cellular Therapy|March 30, 2023
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid LeukemiaRupa Narayan, Abhishek Niroula, Tao Wang, et al.Transplantation and Cellular Therapy|March 29, 2023
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System TumorsTristan E Knight, Kwang Woo Ahn, Kyle M Hebert, et al.Transplantation and Cellular Therapy|March 29, 2021
Efficacy of Allogeneic Hematopoietic Cell Transplantation for Autoimmune DiseasesIman Shifa, Glen S Hazlewood, Caylib Durand, et al.Transplantation and Cellular Therapy|March 29, 2021
Combining Three Different Pretransplantation Scores Improves Predictive Value in Patients after Haploidentical Stem Cell Transplantation with Thiotepa, Busulfan, and Fludarabine Conditioning and Post-Transplantation CyclophosphamideAlbert Esquirol, Maria Jesus Pascual, Irene Garcia-Cadenas, et al.Transplantation and Cellular Therapy|March 30, 2021
American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation RecipientsSanjeet S Dadwal, Tobias M Hohl, Cynthia E Fisher, et al.Transplantation and Cellular Therapy|March 30, 2021
Tear Lipid Metabolites As Potential Diagnostic Biomarkers for Ocular Chronic Graft-Versus-Host DiseaseJiao Ma, Zhan Shen, Rongmei Peng, et al.Transplantation and Cellular Therapy|March 30, 2021
Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia in JapanShiho Wakase, Takanori Teshima, Jie Zhang, et al.Transplantation and Cellular Therapy|March 30, 2021
Influence of Overlapping Genetic Abnormalities on Treatment Outcomes of Multiple MyelomaSamer A Srour, Rima M Saliba, Qaiser Bashir, et al.Transplantation and Cellular Therapy|March 30, 2021
Pretransplantation MRD in Older Patients With AML After Treatment With Decitabine or Conventional ChemotherapyJacobien R Hilberink, Linde M Morsink, Walter J F M van der Velden, et al.Pageof 181